Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1989;67(5):567–575.

Medical approaches to termination of early pregnancy.

P F Van Look, M Bygdeman
PMCID: PMC2491296  PMID: 2692870

Abstract

Termination of early pregnancy by vacuum aspiration is a well-established technique. The procedure is highly effective and has a low complication rate, particularly when performed during the first few weeks after missed menses. However, this parasurgical method requires skilled health care personnel, and attempts have therefore been made to find medical alternatives. Prostaglandins were the first agents to be used successfully for this purpose, but the high incidence of mainly gastrointestinal side-effects has limited their widespread use. More recently, attention has focused on antiprogestational steroids, i.e., compounds that prevent the action of progesterone either by inhibiting its biosynthesis or by preventing it from binding to the cellular receptors in target organs. Current experience indicates that these compounds, particularly when used in combination with a low dose of a synthetic prostaglandin analogue, have the potential to become a safe, effective, and acceptable medical method for the termination of early pregnancy.

Full text

PDF
567

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baulieu E. E., Ulmann A. Antiprogesterone activity of RU 486 and its contragestive and other applications. Hum Reprod. 1986 Feb;1(2):107–110. doi: 10.1093/oxfordjournals.humrep.a136352. [DOI] [PubMed] [Google Scholar]
  2. Birgerson L., Odlind V. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane. Fertil Steril. 1987 Oct;48(4):565–570. doi: 10.1016/s0015-0282(16)59465-5. [DOI] [PubMed] [Google Scholar]
  3. Bygdeman M., Christensen N. J., Gréen K., Zheng S., Lundström V. Termination of early pregnancy. Future development. Acta Obstet Gynecol Scand Suppl. 1983;113:125–129. doi: 10.3109/00016348309155213. [DOI] [PubMed] [Google Scholar]
  4. Bygdeman M., Martin J. N., Jr, Leader A., Lundström V., Ramadan M., Eneroth P., Gréen K. Early pregnancy interruption by 15 (S) 15 methyl prostaglandin F2alpha methyl ester. Obstet Gynecol. 1976 Aug;48(2):221–224. [PubMed] [Google Scholar]
  5. Bygdeman M., Swahn M. L. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy. Contraception. 1985 Jul;32(1):45–51. doi: 10.1016/0010-7824(85)90115-5. [DOI] [PubMed] [Google Scholar]
  6. Bygdeman M., Van Look P. F. Anti-progesterones for the interruption of pregnancy. Baillieres Clin Obstet Gynaecol. 1988 Sep;2(3):617–629. doi: 10.1016/s0950-3552(88)80048-8. [DOI] [PubMed] [Google Scholar]
  7. Cameron I. T., Michie A. F., Baird D. T. Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost). Contraception. 1986 Nov;34(5):459–468. doi: 10.1016/0010-7824(86)90055-7. [DOI] [PubMed] [Google Scholar]
  8. Csapo A. I., Pulkkinen M. Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence. Obstet Gynecol Surv. 1978 Feb;33(2):69–81. doi: 10.1097/00006254-197802000-00001. [DOI] [PubMed] [Google Scholar]
  9. Dubois C., Ulmann A., Aubeny E., Elia D., Jourdan M. C., Van den Bosch M. C., Leton M., Baulieu E. E. Contragestion par le RU 486: intérêt de l'association à un dérivé prostaglandine. C R Acad Sci III. 1988;306(2):57–61. [PubMed] [Google Scholar]
  10. Frank P. I., Kay C. R., Lewis T. L., Parish S. Outcome of pregnancy following induced abortion. Report from the joint study of the Royal College of General Practitioners and the Royal College of Obstetricians and Gynaecologists. Br J Obstet Gynaecol. 1985 Apr;92(4):308–316. doi: 10.1111/j.1471-0528.1985.tb01102.x. [DOI] [PubMed] [Google Scholar]
  11. Gréen K., Bygdeman M., Bremme K. Interruption of early first trimester pregnancy by single vaginal administration of 15-methyl-pgf2 alpha-methyl ester. Contraception. 1978 Dec;18(6):551–560. doi: 10.1016/0010-7824(78)90040-9. [DOI] [PubMed] [Google Scholar]
  12. Hamberger L., Nilsson L., Björn-Rasmussen E., Atterfelt P., Wiqvist N. Early abortion by vaginal prostaglandin suppositories. Blood loss in relation to elimination of serum chorionic gonadotrophin, progesterone and estradiol-17 beta. Contraception. 1978 Feb;17(2):183–193. doi: 10.1016/0010-7824(78)90074-4. [DOI] [PubMed] [Google Scholar]
  13. Kovacs L., Sas M., Resch B. A., Ugocsai G., Swahn M. L., Bygdeman M., Rowe P. J. Termination of very early pregnancy by RU 486--an antiprogestational compound. Contraception. 1984 May;29(5):399–410. doi: 10.1016/0010-7824(84)90014-3. [DOI] [PubMed] [Google Scholar]
  14. Laufe L. E. The menstrual regulation procedure. Stud Fam Plann. 1977 Oct;8(10):253–256. [PubMed] [Google Scholar]
  15. Mackenzie I. Z., Embrey M. P., Davies A. J., Guillebaud J. Very early abortion by prostaglandins. Lancet. 1978 Jun 10;1(8076):1223–1226. doi: 10.1016/s0140-6736(78)92462-5. [DOI] [PubMed] [Google Scholar]
  16. Rodger M. W., Baird D. T. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary. Lancet. 1987 Dec 19;2(8573):1415–1418. doi: 10.1016/s0140-6736(87)91126-3. [DOI] [PubMed] [Google Scholar]
  17. Smith S. K., Baird D. T. The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study. Br J Obstet Gynaecol. 1980 Aug;87(8):712–717. doi: 10.1111/j.1471-0528.1980.tb04605.x. [DOI] [PubMed] [Google Scholar]
  18. Swahn M. L., Ugocsai G., Bygdeman M., Kovacs L., Belsey E. M., Van Look P. F. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy. Hum Reprod. 1989 Jan;4(1):21–28. doi: 10.1093/oxfordjournals.humrep.a136838. [DOI] [PubMed] [Google Scholar]
  19. Ulmann A. Uses of RU 486 for contragestion: an update. Contraception. 1987;36 (Suppl):27–31. doi: 10.1016/0010-7824(87)90119-3. [DOI] [PubMed] [Google Scholar]
  20. Webster M. A., Phipps S. L., Gillmer M. D. Interruption of first trimester human pregnancy following Epostane therapy. Effect of prostaglandin E2 pessaries. Br J Obstet Gynaecol. 1985 Sep;92(9):963–968. doi: 10.1111/j.1471-0528.1985.tb03078.x. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES